BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 10708291)

  • 1. Estimating the population impact in Australia of improved antiretroviral treatment for HIV infection.
    Law MG; Li Y; McDonald AM; Cooper DA; Kaldor JM
    AIDS; 2000 Jan; 14(2):197-201. PubMed ID: 10708291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disproportionate impact of combination antiretroviral therapy on AIDS incidence in Australia: results from a modified back-projection model.
    Wand H; Falster K; Wilson D; Law M; Maher L
    AIDS Behav; 2012 Feb; 16(2):360-7. PubMed ID: 21598032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of antiretroviral combination therapies on AIDS surveillance reports in Switzerland. Swiss HIV Cohort Study.
    Gebhardt M; Rickenbach M; Egger M
    AIDS; 1998 Jul; 12(10):1195-201. PubMed ID: 9677169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AIDS diagnoses at higher CD4 counts in Australia following the introduction of highly active antiretroviral treatment.
    Law MG; de Winter L; McDonald A; Cooper DA; Kaldor JM
    AIDS; 1999 Feb; 13(2):263-9. PubMed ID: 10202833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Age-specific HIV incidence among homosexually active men in Australia.
    Law MG; Rosenberg PS; McDonald A; Kaldor JM
    Med J Aust; 1996 Jun; 164(12):715-8. PubMed ID: 8668076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increasing survival time after AIDS in Italy: the role of new combination antiretroviral therapies. Tuscany AIDS Study Group.
    Pezzotti P; Napoli PA; Acciai S; Boros S; Urciuoli R; Lazzeri V; Rezza G
    AIDS; 1999 Feb; 13(2):249-55. PubMed ID: 10202831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination antiretroviral therapy and recent declines in AIDS incidence and mortality.
    Vittinghoff E; Scheer S; O'Malley P; Colfax G; Holmberg SD; Buchbinder SP
    J Infect Dis; 1999 Mar; 179(3):717-20. PubMed ID: 9952385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing the extent of the Australian HIV epidemic from AIDS surveillance data.
    Becker NG; Watson LF; Marschner IC; Motika M; Newstead SV; Carlin JB
    Aust J Public Health; 1993 Sep; 17(3):226-31. PubMed ID: 8286495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Marked improvement in survival following AIDS dementia complex in the era of highly active antiretroviral therapy.
    Dore GJ; McDonald A; Li Y; Kaldor JM; Brew BJ;
    AIDS; 2003 Jul; 17(10):1539-45. PubMed ID: 12824792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Time from HIV-1 seroconversion to AIDS and death before widespread use of highly-active antiretroviral therapy: a collaborative re-analysis. Collaborative Group on AIDS Incubation and HIV Survival including the CASCADE EU Concerted Action. Concerted Action on SeroConversion to AIDS and Death in Europe.
    Lancet; 2000 Apr; 355(9210):1131-7. PubMed ID: 10791375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of back projection to estimate HIV prevalence among pregnant women in Australia.
    Law MG; Dore G; McDonald A; Kaldor J
    Pediatr AIDS HIV Infect; 1996 Oct; 7(5):331-6. PubMed ID: 11361491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes to AIDS dementia complex in the era of highly active antiretroviral therapy.
    Dore GJ; Correll PK; Li Y; Kaldor JM; Cooper DA; Brew BJ
    AIDS; 1999 Jul; 13(10):1249-53. PubMed ID: 10416530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving survival following AIDS in Australia, 1991-1996. National HIV Surveillance Committee.
    Li Y; McDonald AM; Dore GJ; Kaldor JM
    AIDS; 2000 Oct; 14(15):2349-54. PubMed ID: 11089623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ten-year trends in CD4 cell counts at HIV and AIDS diagnosis in a London HIV clinic.
    Easterbrook PJ; Yu LM; Goetghebeur E; Boag F; McLean K; Gazzard B
    AIDS; 2000 Mar; 14(5):561-71. PubMed ID: 10780719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The changing incidence of AIDS events in patients receiving highly active antiretroviral therapy.
    d'Arminio Monforte A; Sabin CA; Phillips A; Sterne J; May M; Justice A; Dabis F; Grabar S; Ledergerber B; Gill J; Reiss P; Egger M;
    Arch Intern Med; 2005 Feb; 165(4):416-23. PubMed ID: 15738371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of HIV testing rates among HIV infected individuals using incidence data on HIV and AIDS diagnoses.
    Marschner IC
    Stat Med; 1996 Mar; 15(5):497-511. PubMed ID: 8668874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimating HIV incidence using dates of both HIV and AIDS diagnoses.
    Cui J; Becker NG
    Stat Med; 2000 May; 19(9):1165-77. PubMed ID: 10797514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The incidence and prevalence of AIDS and prevalence of other severe HIV disease in England and Wales for 1995 to 1999: projections using data to the end of 1994.
    Commun Dis Rep CDR Rev; 1996 Jan; 6(1):R1-21. PubMed ID: 8581117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting AIDS deaths and prevalence in Australia.
    Solomon PJ; Wilson SR
    Med J Aust; 1992 Jul; 157(2):121-5. PubMed ID: 1630375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AIDS in Brazilian children: history, surveillance, antiretroviral therapy, and epidemiologic transition, 1984-2008.
    Ramos AN; Matida LH; Hearst N; Heukelbach J
    AIDS Patient Care STDS; 2011 Apr; 25(4):245-55. PubMed ID: 21413856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.